Global Cell Therapy Regenerative Medicine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
LPI (LP Information)' newest research report, the “Cell Therapy Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Cell Therapy Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Therapy Regenerative Medicine sales for 2023 through 2029. With Cell Therapy Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Therapy Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cell Therapy Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Regenerative Medicine.
The global Cell Therapy Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Therapy Regenerative Medicine players cover DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Cell Therapy Regenerative Medicine market?
What factors are driving Cell Therapy Regenerative Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell Therapy Regenerative Medicine market opportunities vary by end market size?
How does Cell Therapy Regenerative Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
LPI (LP Information)' newest research report, the “Cell Therapy Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Cell Therapy Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Therapy Regenerative Medicine sales for 2023 through 2029. With Cell Therapy Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Therapy Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cell Therapy Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Regenerative Medicine.
The global Cell Therapy Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Therapy Regenerative Medicine players cover DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- NK Cell Therapy
- CAR-T Cell Therapy
- Others
- Dermatology
- Cardiovascular
- Central Nervous System
- Plastic Surgery
- Other Medical Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- DePuy Synthes
- Medtronic
- ZimmerBiomet
- Stryker
- Acelity
- MiMedx Group
- Organogenesis
- UniQure
- Cellular Dynamics International
- Osiris Therapeutics
- Vcanbio
- Gamida Cell
- Golden Meditech
- Cytori
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- Stemcell Technologies
- Bellicum Pharmaceuticals
What is the 10-year outlook for the global Cell Therapy Regenerative Medicine market?
What factors are driving Cell Therapy Regenerative Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell Therapy Regenerative Medicine market opportunities vary by end market size?
How does Cell Therapy Regenerative Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy Regenerative Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Country/Region, 2018, 2022 & 2029
2.2 Cell Therapy Regenerative Medicine Segment by Type
2.2.1 NK Cell Therapy
2.2.2 CAR-T Cell Therapy
2.2.3 Others
2.3 Cell Therapy Regenerative Medicine Sales by Type
2.3.1 Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023)
2.4 Cell Therapy Regenerative Medicine Segment by Application
2.4.1 Dermatology
2.4.2 Cardiovascular
2.4.3 Central Nervous System
2.4.4 Plastic Surgery
2.4.5 Other Medical Applications
2.5 Cell Therapy Regenerative Medicine Sales by Application
2.5.1 Global Cell Therapy Regenerative Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023)
3 GLOBAL CELL THERAPY REGENERATIVE MEDICINE BY COMPANY
3.1 Global Cell Therapy Regenerative Medicine Breakdown Data by Company
3.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023)
3.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023)
3.2.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Cell Therapy Regenerative Medicine Sale Price by Company
3.4 Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell Therapy Regenerative Medicine Product Location Distribution
3.4.2 Players Cell Therapy Regenerative Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELL THERAPY REGENERATIVE MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Cell Therapy Regenerative Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cell Therapy Regenerative Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Cell Therapy Regenerative Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cell Therapy Regenerative Medicine Sales Growth
4.4 APAC Cell Therapy Regenerative Medicine Sales Growth
4.5 Europe Cell Therapy Regenerative Medicine Sales Growth
4.6 Middle East & Africa Cell Therapy Regenerative Medicine Sales Growth
5 AMERICAS
5.1 Americas Cell Therapy Regenerative Medicine Sales by Country
5.1.1 Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
5.1.2 Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
5.2 Americas Cell Therapy Regenerative Medicine Sales by Type
5.3 Americas Cell Therapy Regenerative Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy Regenerative Medicine Sales by Region
6.1.1 APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023)
6.1.2 APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023)
6.2 APAC Cell Therapy Regenerative Medicine Sales by Type
6.3 APAC Cell Therapy Regenerative Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cell Therapy Regenerative Medicine by Country
7.1.1 Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
7.1.2 Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
7.2 Europe Cell Therapy Regenerative Medicine Sales by Type
7.3 Europe Cell Therapy Regenerative Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy Regenerative Medicine by Country
8.1.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type
8.3 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine
10.3 Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
10.4 Industry Chain Structure of Cell Therapy Regenerative Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell Therapy Regenerative Medicine Distributors
11.3 Cell Therapy Regenerative Medicine Customer
12 WORLD FORECAST REVIEW FOR CELL THERAPY REGENERATIVE MEDICINE BY GEOGRAPHIC REGION
12.1 Global Cell Therapy Regenerative Medicine Market Size Forecast by Region
12.1.1 Global Cell Therapy Regenerative Medicine Forecast by Region (2024-2029)
12.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell Therapy Regenerative Medicine Forecast by Type
12.7 Global Cell Therapy Regenerative Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 DePuy Synthes
13.1.1 DePuy Synthes Company Information
13.1.2 DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DePuy Synthes Main Business Overview
13.1.5 DePuy Synthes Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.2.3 Medtronic Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet Company Information
13.3.2 ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ZimmerBiomet Main Business Overview
13.3.5 ZimmerBiomet Latest Developments
13.4 Stryker
13.4.1 Stryker Company Information
13.4.2 Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.4.3 Stryker Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Stryker Main Business Overview
13.4.5 Stryker Latest Developments
13.5 Acelity
13.5.1 Acelity Company Information
13.5.2 Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.5.3 Acelity Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Acelity Main Business Overview
13.5.5 Acelity Latest Developments
13.6 MiMedx Group
13.6.1 MiMedx Group Company Information
13.6.2 MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.6.3 MiMedx Group Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MiMedx Group Main Business Overview
13.6.5 MiMedx Group Latest Developments
13.7 Organogenesis
13.7.1 Organogenesis Company Information
13.7.2 Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.7.3 Organogenesis Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Organogenesis Main Business Overview
13.7.5 Organogenesis Latest Developments
13.8 UniQure
13.8.1 UniQure Company Information
13.8.2 UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.8.3 UniQure Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 UniQure Main Business Overview
13.8.5 UniQure Latest Developments
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Information
13.9.2 Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cellular Dynamics International Main Business Overview
13.9.5 Cellular Dynamics International Latest Developments
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Information
13.10.2 Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Osiris Therapeutics Main Business Overview
13.10.5 Osiris Therapeutics Latest Developments
13.11 Vcanbio
13.11.1 Vcanbio Company Information
13.11.2 Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.11.3 Vcanbio Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Vcanbio Main Business Overview
13.11.5 Vcanbio Latest Developments
13.12 Gamida Cell
13.12.1 Gamida Cell Company Information
13.12.2 Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.12.3 Gamida Cell Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Gamida Cell Main Business Overview
13.12.5 Gamida Cell Latest Developments
13.13 Golden Meditech
13.13.1 Golden Meditech Company Information
13.13.2 Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.13.3 Golden Meditech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Golden Meditech Main Business Overview
13.13.5 Golden Meditech Latest Developments
13.14 Cytori
13.14.1 Cytori Company Information
13.14.2 Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.14.3 Cytori Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Cytori Main Business Overview
13.14.5 Cytori Latest Developments
13.15 Celgene
13.15.1 Celgene Company Information
13.15.2 Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.15.3 Celgene Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Celgene Main Business Overview
13.15.5 Celgene Latest Developments
13.16 Vericel Corporation
13.16.1 Vericel Corporation Company Information
13.16.2 Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Vericel Corporation Main Business Overview
13.16.5 Vericel Corporation Latest Developments
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech Company Information
13.17.2 Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Guanhao Biotech Main Business Overview
13.17.5 Guanhao Biotech Latest Developments
13.18 Mesoblast
13.18.1 Mesoblast Company Information
13.18.2 Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.18.3 Mesoblast Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mesoblast Main Business Overview
13.18.5 Mesoblast Latest Developments
13.19 Stemcell Technologies
13.19.1 Stemcell Technologies Company Information
13.19.2 Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Stemcell Technologies Main Business Overview
13.19.5 Stemcell Technologies Latest Developments
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals Company Information
13.20.2 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Bellicum Pharmaceuticals Main Business Overview
13.20.5 Bellicum Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy Regenerative Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Country/Region, 2018, 2022 & 2029
2.2 Cell Therapy Regenerative Medicine Segment by Type
2.2.1 NK Cell Therapy
2.2.2 CAR-T Cell Therapy
2.2.3 Others
2.3 Cell Therapy Regenerative Medicine Sales by Type
2.3.1 Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023)
2.4 Cell Therapy Regenerative Medicine Segment by Application
2.4.1 Dermatology
2.4.2 Cardiovascular
2.4.3 Central Nervous System
2.4.4 Plastic Surgery
2.4.5 Other Medical Applications
2.5 Cell Therapy Regenerative Medicine Sales by Application
2.5.1 Global Cell Therapy Regenerative Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023)
3 GLOBAL CELL THERAPY REGENERATIVE MEDICINE BY COMPANY
3.1 Global Cell Therapy Regenerative Medicine Breakdown Data by Company
3.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023)
3.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023)
3.2.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Cell Therapy Regenerative Medicine Sale Price by Company
3.4 Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell Therapy Regenerative Medicine Product Location Distribution
3.4.2 Players Cell Therapy Regenerative Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELL THERAPY REGENERATIVE MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Cell Therapy Regenerative Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cell Therapy Regenerative Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Cell Therapy Regenerative Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cell Therapy Regenerative Medicine Sales Growth
4.4 APAC Cell Therapy Regenerative Medicine Sales Growth
4.5 Europe Cell Therapy Regenerative Medicine Sales Growth
4.6 Middle East & Africa Cell Therapy Regenerative Medicine Sales Growth
5 AMERICAS
5.1 Americas Cell Therapy Regenerative Medicine Sales by Country
5.1.1 Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
5.1.2 Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
5.2 Americas Cell Therapy Regenerative Medicine Sales by Type
5.3 Americas Cell Therapy Regenerative Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy Regenerative Medicine Sales by Region
6.1.1 APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023)
6.1.2 APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023)
6.2 APAC Cell Therapy Regenerative Medicine Sales by Type
6.3 APAC Cell Therapy Regenerative Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cell Therapy Regenerative Medicine by Country
7.1.1 Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
7.1.2 Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
7.2 Europe Cell Therapy Regenerative Medicine Sales by Type
7.3 Europe Cell Therapy Regenerative Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy Regenerative Medicine by Country
8.1.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type
8.3 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine
10.3 Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
10.4 Industry Chain Structure of Cell Therapy Regenerative Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell Therapy Regenerative Medicine Distributors
11.3 Cell Therapy Regenerative Medicine Customer
12 WORLD FORECAST REVIEW FOR CELL THERAPY REGENERATIVE MEDICINE BY GEOGRAPHIC REGION
12.1 Global Cell Therapy Regenerative Medicine Market Size Forecast by Region
12.1.1 Global Cell Therapy Regenerative Medicine Forecast by Region (2024-2029)
12.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell Therapy Regenerative Medicine Forecast by Type
12.7 Global Cell Therapy Regenerative Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 DePuy Synthes
13.1.1 DePuy Synthes Company Information
13.1.2 DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DePuy Synthes Main Business Overview
13.1.5 DePuy Synthes Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.2.3 Medtronic Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet Company Information
13.3.2 ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ZimmerBiomet Main Business Overview
13.3.5 ZimmerBiomet Latest Developments
13.4 Stryker
13.4.1 Stryker Company Information
13.4.2 Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.4.3 Stryker Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Stryker Main Business Overview
13.4.5 Stryker Latest Developments
13.5 Acelity
13.5.1 Acelity Company Information
13.5.2 Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.5.3 Acelity Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Acelity Main Business Overview
13.5.5 Acelity Latest Developments
13.6 MiMedx Group
13.6.1 MiMedx Group Company Information
13.6.2 MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.6.3 MiMedx Group Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MiMedx Group Main Business Overview
13.6.5 MiMedx Group Latest Developments
13.7 Organogenesis
13.7.1 Organogenesis Company Information
13.7.2 Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.7.3 Organogenesis Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Organogenesis Main Business Overview
13.7.5 Organogenesis Latest Developments
13.8 UniQure
13.8.1 UniQure Company Information
13.8.2 UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.8.3 UniQure Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 UniQure Main Business Overview
13.8.5 UniQure Latest Developments
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Information
13.9.2 Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cellular Dynamics International Main Business Overview
13.9.5 Cellular Dynamics International Latest Developments
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Information
13.10.2 Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Osiris Therapeutics Main Business Overview
13.10.5 Osiris Therapeutics Latest Developments
13.11 Vcanbio
13.11.1 Vcanbio Company Information
13.11.2 Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.11.3 Vcanbio Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Vcanbio Main Business Overview
13.11.5 Vcanbio Latest Developments
13.12 Gamida Cell
13.12.1 Gamida Cell Company Information
13.12.2 Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.12.3 Gamida Cell Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Gamida Cell Main Business Overview
13.12.5 Gamida Cell Latest Developments
13.13 Golden Meditech
13.13.1 Golden Meditech Company Information
13.13.2 Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.13.3 Golden Meditech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Golden Meditech Main Business Overview
13.13.5 Golden Meditech Latest Developments
13.14 Cytori
13.14.1 Cytori Company Information
13.14.2 Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.14.3 Cytori Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Cytori Main Business Overview
13.14.5 Cytori Latest Developments
13.15 Celgene
13.15.1 Celgene Company Information
13.15.2 Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.15.3 Celgene Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Celgene Main Business Overview
13.15.5 Celgene Latest Developments
13.16 Vericel Corporation
13.16.1 Vericel Corporation Company Information
13.16.2 Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Vericel Corporation Main Business Overview
13.16.5 Vericel Corporation Latest Developments
13.17 Guanhao Biotech
13.17.1 Guanhao Biotech Company Information
13.17.2 Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Guanhao Biotech Main Business Overview
13.17.5 Guanhao Biotech Latest Developments
13.18 Mesoblast
13.18.1 Mesoblast Company Information
13.18.2 Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.18.3 Mesoblast Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mesoblast Main Business Overview
13.18.5 Mesoblast Latest Developments
13.19 Stemcell Technologies
13.19.1 Stemcell Technologies Company Information
13.19.2 Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Stemcell Technologies Main Business Overview
13.19.5 Stemcell Technologies Latest Developments
13.20 Bellicum Pharmaceuticals
13.20.1 Bellicum Pharmaceuticals Company Information
13.20.2 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications
13.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Bellicum Pharmaceuticals Main Business Overview
13.20.5 Bellicum Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Therapy Regenerative Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cell Therapy Regenerative Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NK Cell Therapy
Table 4. Major Players of CAR-T Cell Therapy
Table 5. Major Players of Others
Table 6. Global Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 7. Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Table 8. Global Cell Therapy Regenerative Medicine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023)
Table 10. Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Table 13. Global Cell Therapy Regenerative Medicine Revenue by Application (2018-2023)
Table 14. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2018-2023)
Table 15. Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Cell Therapy Regenerative Medicine Sales by Company (2018-2023) & (K Units)
Table 17. Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023)
Table 18. Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023)
Table 20. Global Cell Therapy Regenerative Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution and Sales Area
Table 22. Players Cell Therapy Regenerative Medicine Products Offered
Table 23. Cell Therapy Regenerative Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cell Therapy Regenerative Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Cell Therapy Regenerative Medicine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Cell Therapy Regenerative Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Cell Therapy Regenerative Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Cell Therapy Regenerative Medicine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Cell Therapy Regenerative Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Cell Therapy Regenerative Medicine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 36. Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 38. Americas Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region (2018-2023)
Table 42. APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Region (2018-2023)
Table 44. APAC Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 48. Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 50. Europe Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Cell Therapy Regenerative Medicine
Table 59. Key Market Challenges & Risks of Cell Therapy Regenerative Medicine
Table 60. Key Industry Trends of Cell Therapy Regenerative Medicine
Table 61. Cell Therapy Regenerative Medicine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Cell Therapy Regenerative Medicine Distributors List
Table 64. Cell Therapy Regenerative Medicine Customer List
Table 65. Global Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Cell Therapy Regenerative Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Cell Therapy Regenerative Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Cell Therapy Regenerative Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Cell Therapy Regenerative Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. DePuy Synthes Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 81. DePuy Synthes Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. DePuy Synthes Main Business
Table 83. DePuy Synthes Latest Developments
Table 84. Medtronic Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 86. Medtronic Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. ZimmerBiomet Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 91. ZimmerBiomet Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. ZimmerBiomet Main Business
Table 93. ZimmerBiomet Latest Developments
Table 94. Stryker Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 96. Stryker Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Stryker Main Business
Table 98. Stryker Latest Developments
Table 99. Acelity Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 101. Acelity Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Acelity Main Business
Table 103. Acelity Latest Developments
Table 104. MiMedx Group Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 106. MiMedx Group Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. MiMedx Group Main Business
Table 108. MiMedx Group Latest Developments
Table 109. Organogenesis Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 111. Organogenesis Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Organogenesis Main Business
Table 113. Organogenesis Latest Developments
Table 114. UniQure Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 116. UniQure Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. UniQure Main Business
Table 118. UniQure Latest Developments
Table 119. Cellular Dynamics International Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 121. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Cellular Dynamics International Main Business
Table 123. Cellular Dynamics International Latest Developments
Table 124. Osiris Therapeutics Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 126. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Osiris Therapeutics Main Business
Table 128. Osiris Therapeutics Latest Developments
Table 129. Vcanbio Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 131. Vcanbio Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Vcanbio Main Business
Table 133. Vcanbio Latest Developments
Table 134. Gamida Cell Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 135. Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 136. Gamida Cell Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Gamida Cell Main Business
Table 138. Gamida Cell Latest Developments
Table 139. Golden Meditech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 140. Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 141. Golden Meditech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Golden Meditech Main Business
Table 143. Golden Meditech Latest Developments
Table 144. Cytori Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 145. Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 146. Cytori Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Cytori Main Business
Table 148. Cytori Latest Developments
Table 149. Celgene Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 150. Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 151. Celgene Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Celgene Main Business
Table 153. Celgene Latest Developments
Table 154. Vericel Corporation Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 155. Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 156. Vericel Corporation Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Vericel Corporation Main Business
Table 158. Vericel Corporation Latest Developments
Table 159. Guanhao Biotech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 160. Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 161. Guanhao Biotech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Guanhao Biotech Main Business
Table 163. Guanhao Biotech Latest Developments
Table 164. Mesoblast Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 165. Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 166. Mesoblast Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Mesoblast Main Business
Table 168. Mesoblast Latest Developments
Table 169. Stemcell Technologies Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 170. Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 171. Stemcell Technologies Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Stemcell Technologies Main Business
Table 173. Stemcell Technologies Latest Developments
Table 174. Bellicum Pharmaceuticals Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 175. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 176. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Bellicum Pharmaceuticals Main Business
Table 178. Bellicum Pharmaceuticals Latest Developments
Table 1. Cell Therapy Regenerative Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cell Therapy Regenerative Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NK Cell Therapy
Table 4. Major Players of CAR-T Cell Therapy
Table 5. Major Players of Others
Table 6. Global Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 7. Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Table 8. Global Cell Therapy Regenerative Medicine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023)
Table 10. Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Table 13. Global Cell Therapy Regenerative Medicine Revenue by Application (2018-2023)
Table 14. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2018-2023)
Table 15. Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Cell Therapy Regenerative Medicine Sales by Company (2018-2023) & (K Units)
Table 17. Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023)
Table 18. Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023)
Table 20. Global Cell Therapy Regenerative Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution and Sales Area
Table 22. Players Cell Therapy Regenerative Medicine Products Offered
Table 23. Cell Therapy Regenerative Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cell Therapy Regenerative Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Cell Therapy Regenerative Medicine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Cell Therapy Regenerative Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Cell Therapy Regenerative Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Cell Therapy Regenerative Medicine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Cell Therapy Regenerative Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Cell Therapy Regenerative Medicine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 36. Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 38. Americas Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region (2018-2023)
Table 42. APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Region (2018-2023)
Table 44. APAC Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 48. Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 50. Europe Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Cell Therapy Regenerative Medicine
Table 59. Key Market Challenges & Risks of Cell Therapy Regenerative Medicine
Table 60. Key Industry Trends of Cell Therapy Regenerative Medicine
Table 61. Cell Therapy Regenerative Medicine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Cell Therapy Regenerative Medicine Distributors List
Table 64. Cell Therapy Regenerative Medicine Customer List
Table 65. Global Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Cell Therapy Regenerative Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Cell Therapy Regenerative Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Cell Therapy Regenerative Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Cell Therapy Regenerative Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Cell Therapy Regenerative Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Cell Therapy Regenerative Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Cell Therapy Regenerative Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. DePuy Synthes Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 81. DePuy Synthes Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. DePuy Synthes Main Business
Table 83. DePuy Synthes Latest Developments
Table 84. Medtronic Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 86. Medtronic Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. ZimmerBiomet Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 91. ZimmerBiomet Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. ZimmerBiomet Main Business
Table 93. ZimmerBiomet Latest Developments
Table 94. Stryker Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 96. Stryker Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Stryker Main Business
Table 98. Stryker Latest Developments
Table 99. Acelity Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 101. Acelity Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Acelity Main Business
Table 103. Acelity Latest Developments
Table 104. MiMedx Group Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 106. MiMedx Group Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. MiMedx Group Main Business
Table 108. MiMedx Group Latest Developments
Table 109. Organogenesis Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 111. Organogenesis Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Organogenesis Main Business
Table 113. Organogenesis Latest Developments
Table 114. UniQure Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 116. UniQure Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. UniQure Main Business
Table 118. UniQure Latest Developments
Table 119. Cellular Dynamics International Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 121. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Cellular Dynamics International Main Business
Table 123. Cellular Dynamics International Latest Developments
Table 124. Osiris Therapeutics Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 126. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Osiris Therapeutics Main Business
Table 128. Osiris Therapeutics Latest Developments
Table 129. Vcanbio Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 131. Vcanbio Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Vcanbio Main Business
Table 133. Vcanbio Latest Developments
Table 134. Gamida Cell Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 135. Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 136. Gamida Cell Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Gamida Cell Main Business
Table 138. Gamida Cell Latest Developments
Table 139. Golden Meditech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 140. Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 141. Golden Meditech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Golden Meditech Main Business
Table 143. Golden Meditech Latest Developments
Table 144. Cytori Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 145. Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 146. Cytori Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Cytori Main Business
Table 148. Cytori Latest Developments
Table 149. Celgene Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 150. Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 151. Celgene Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Celgene Main Business
Table 153. Celgene Latest Developments
Table 154. Vericel Corporation Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 155. Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 156. Vericel Corporation Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Vericel Corporation Main Business
Table 158. Vericel Corporation Latest Developments
Table 159. Guanhao Biotech Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 160. Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 161. Guanhao Biotech Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Guanhao Biotech Main Business
Table 163. Guanhao Biotech Latest Developments
Table 164. Mesoblast Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 165. Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 166. Mesoblast Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Mesoblast Main Business
Table 168. Mesoblast Latest Developments
Table 169. Stemcell Technologies Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 170. Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 171. Stemcell Technologies Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Stemcell Technologies Main Business
Table 173. Stemcell Technologies Latest Developments
Table 174. Bellicum Pharmaceuticals Basic Information, Cell Therapy Regenerative Medicine Manufacturing Base, Sales Area and Its Competitors
Table 175. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications
Table 176. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Bellicum Pharmaceuticals Main Business
Table 178. Bellicum Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cell Therapy Regenerative Medicine
Figure 2. Cell Therapy Regenerative Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cell Therapy Regenerative Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Cell Therapy Regenerative Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cell Therapy Regenerative Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NK Cell Therapy
Figure 10. Product Picture of CAR-T Cell Therapy
Figure 11. Product Picture of Others
Figure 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Type in 2022
Figure 13. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023)
Figure 14. Cell Therapy Regenerative Medicine Consumed in Dermatology
Figure 15. Global Cell Therapy Regenerative Medicine Market: Dermatology (2018-2023) & (K Units)
Figure 16. Cell Therapy Regenerative Medicine Consumed in Cardiovascular
Figure 17. Global Cell Therapy Regenerative Medicine Market: Cardiovascular (2018-2023) & (K Units)
Figure 18. Cell Therapy Regenerative Medicine Consumed in Central Nervous System
Figure 19. Global Cell Therapy Regenerative Medicine Market: Central Nervous System (2018-2023) & (K Units)
Figure 20. Cell Therapy Regenerative Medicine Consumed in Plastic Surgery
Figure 21. Global Cell Therapy Regenerative Medicine Market: Plastic Surgery (2018-2023) & (K Units)
Figure 22. Cell Therapy Regenerative Medicine Consumed in Other Medical Applications
Figure 23. Global Cell Therapy Regenerative Medicine Market: Other Medical Applications (2018-2023) & (K Units)
Figure 24. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2022)
Figure 25. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application in 2022
Figure 26. Cell Therapy Regenerative Medicine Sales Market by Company in 2022 (K Units)
Figure 27. Global Cell Therapy Regenerative Medicine Sales Market Share by Company in 2022
Figure 28. Cell Therapy Regenerative Medicine Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company in 2022
Figure 30. Global Cell Therapy Regenerative Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 33. Americas Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 34. APAC Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 35. APAC Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 36. Europe Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 37. Europe Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 40. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 41. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 42. Americas Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 43. Americas Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 44. United States Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region in 2022
Figure 49. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Regions in 2022
Figure 50. APAC Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 51. APAC Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 52. China Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 60. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 61. Europe Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 62. Europe Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 63. Germany Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 72. Egypt Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine in 2022
Figure 78. Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
Figure 79. Industry Chain Structure of Cell Therapy Regenerative Medicine
Figure 80. Channels of Distribution
Figure 81. Global Cell Therapy Regenerative Medicine Sales Market Forecast by Region (2024-2029)
Figure 82. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Cell Therapy Regenerative Medicine
Figure 2. Cell Therapy Regenerative Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cell Therapy Regenerative Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Cell Therapy Regenerative Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cell Therapy Regenerative Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NK Cell Therapy
Figure 10. Product Picture of CAR-T Cell Therapy
Figure 11. Product Picture of Others
Figure 12. Global Cell Therapy Regenerative Medicine Sales Market Share by Type in 2022
Figure 13. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023)
Figure 14. Cell Therapy Regenerative Medicine Consumed in Dermatology
Figure 15. Global Cell Therapy Regenerative Medicine Market: Dermatology (2018-2023) & (K Units)
Figure 16. Cell Therapy Regenerative Medicine Consumed in Cardiovascular
Figure 17. Global Cell Therapy Regenerative Medicine Market: Cardiovascular (2018-2023) & (K Units)
Figure 18. Cell Therapy Regenerative Medicine Consumed in Central Nervous System
Figure 19. Global Cell Therapy Regenerative Medicine Market: Central Nervous System (2018-2023) & (K Units)
Figure 20. Cell Therapy Regenerative Medicine Consumed in Plastic Surgery
Figure 21. Global Cell Therapy Regenerative Medicine Market: Plastic Surgery (2018-2023) & (K Units)
Figure 22. Cell Therapy Regenerative Medicine Consumed in Other Medical Applications
Figure 23. Global Cell Therapy Regenerative Medicine Market: Other Medical Applications (2018-2023) & (K Units)
Figure 24. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2022)
Figure 25. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application in 2022
Figure 26. Cell Therapy Regenerative Medicine Sales Market by Company in 2022 (K Units)
Figure 27. Global Cell Therapy Regenerative Medicine Sales Market Share by Company in 2022
Figure 28. Cell Therapy Regenerative Medicine Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Cell Therapy Regenerative Medicine Revenue Market Share by Company in 2022
Figure 30. Global Cell Therapy Regenerative Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Cell Therapy Regenerative Medicine Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 33. Americas Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 34. APAC Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 35. APAC Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 36. Europe Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 37. Europe Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Cell Therapy Regenerative Medicine Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Cell Therapy Regenerative Medicine Revenue 2018-2023 ($ Millions)
Figure 40. Americas Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 41. Americas Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 42. Americas Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 43. Americas Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 44. United States Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Cell Therapy Regenerative Medicine Sales Market Share by Region in 2022
Figure 49. APAC Cell Therapy Regenerative Medicine Revenue Market Share by Regions in 2022
Figure 50. APAC Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 51. APAC Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 52. China Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 60. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 61. Europe Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 62. Europe Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 63. Germany Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Figure 72. Egypt Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Cell Therapy Regenerative Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine in 2022
Figure 78. Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
Figure 79. Industry Chain Structure of Cell Therapy Regenerative Medicine
Figure 80. Channels of Distribution
Figure 81. Global Cell Therapy Regenerative Medicine Sales Market Forecast by Region (2024-2029)
Figure 82. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Cell Therapy Regenerative Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Cell Therapy Regenerative Medicine Revenue Market Share Forecast by Application (2024-2029)
